Syndivia

Developer of antibody drug conjugates for cancer treatment

placeStrasbourg, Grand Est, France calendar_todayFounded 2014 groups5 employees language syndivia.com

Innovation

4 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 99 times.

YearFilings
20192
20202
20211
20231
20242
20253

Social engagement

Social engagement: 1.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Bpifrance, Capital Grand Est.

Investor typeCountShare
Private equity125%
Accelerator & incubator125%
Bank & private debt125%
Other / undisclosed125%
Coming soon